has been cited by the following article(s):
[1]
|
New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study
International Journal of Neonatal Screening,
2022
DOI:10.3390/ijns8010015
|
|
|
[2]
|
SMA carrier testing using Real-time PCR as a potential preconception screening tool
Egyptian Journal of Medical Human Genetics,
2022
DOI:10.1186/s43042-022-00233-9
|
|
|
[3]
|
Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs
International Journal of Neonatal Screening,
2021
DOI:10.3390/ijns7030053
|
|
|
[4]
|
Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots
International Journal of Neonatal Screening,
2020
DOI:10.3390/ijns6020043
|
|
|
[5]
|
High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR
European Journal of Human Genetics,
2019
DOI:10.1038/s41431-019-0476-4
|
|
|
[6]
|
Spinal muscular dystrophy – a revisit of the diagnosis and treatment modalities
International Journal of Neuroscience,
2019
DOI:10.1080/00207454.2019.1635128
|
|
|
[7]
|
Relationships between long-term observations of motor milestones and genotype analysis results in childhood-onset Japanese spinal muscular atrophy patients
Brain and Development,
2017
DOI:10.1016/j.braindev.2017.04.018
|
|
|